1. Fan W, Zeng ZY. Response rate of nasopharyngeal carcinoma bone metastasis treated with 153Sm-EDTMP. Chin J Cancer (Chinese), 1997, 16: 291–292.
2. Turner JH, Martindale AA, Sorby P, et al. Samarium-153 EDTMP therapy of disseminated skeletal metastasis. Eur J Nucl Med, 1989, 15: 784–795.
3. Jiang CY, Yang YF, Diao GP, et al. A study of therapeutic dose of 153Sm-EDTMP. Chin J Nucl Med (Chinese), 1998, 18: 222–224.
4. Fan W, Liu F, Zeng ZY, et al. Comparison of treatment result with 89Sr and 153Sm-EDTMP in NPC patients with bone metastases. Chin J Cancer (Chinese), 2000, 19: 586–588.
5. Chen LX, Liu XW, You RA, et al. Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation. Med Phys, 2006, 33: 761–769.